Evidence map›Paper›PMID 33960028›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice.

Elisa Félix-Soriano, Neira Sáinz, Eva Gil-Iturbe, María Collantes, Marta Fernández-Galilea, Rosa Castilla-Madrigal, Lucy Ly, Jesmond Dalli, María J Moreno-Aliaga

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  13. Review
  14. Review
  15. Inflammation and resolution in obesity.Nature reviews. Endocrinology · 2025 · on this map
    Review
  16. Review
  17. Review
  18. Brown Adipose Tissue Activation in Humans Increases Plasma Levels of Lipid Mediators.The Journal of clinical endocrinology and metabolism · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Elisa Félix-SorianoCenter for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.ORCID 0000-0003-4633-1289
Neira SáinzCenter for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.ORCID 0000-0003-0298-3031
Eva Gil-IturbeCenter for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.ORCID 0000-0002-4046-5756
María CollantesRadiopharmacy, Radionanopharmacology and Translational Molecular Imaging Research Group, Clínica Universidad de Navarra, Pamplona, Spain.ORCID 0000-0003-1162-1470
Marta Fernández-GalileaCenter for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.ORCID 0000-0002-4822-3188
Rosa Castilla-MadrigalCenter for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.ORCID 0000-0002-7610-1516
Lucy LyWilliam Harvey Research Institute, Queen Mary University of London, London, UK.
Jesmond DalliWilliam Harvey Research Institute, Queen Mary University of London, London, UK.ORCID 0000-0001-6328-3640
María J Moreno-AliagaCenter for Nutrition Research, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.ORCID 0000-0002-2018-6434
Universidad de Navarra · ESNavarre Institute of Health Research · ESQueen Mary University of London · GBInstituto de Salud Carlos III · ES

Funding

Wellcome TrustWellcome Trust 107613/Z/15/Z
6 · The paper itself

Abstract

Brown adipose tissue (BAT) dysfunction in aging and obesity has been related to chronic unresolved inflammation, which could be mediated by an impaired production of specialized proresolving lipid mediators (SPMs), such as Lipoxins-LXs, Resolvins-Rvs, Protectins-PDs, and Maresins-MaRs. Our aim was to characterize the changes in BAT SPMs signatures and their association with BAT dysfunction during aging, especially under obesogenic conditions, and their modulation by a docosahexaenoic acid (DHA)-rich diet. Lipidomic, functional, and molecular studies were performed in BAT of 2- and 18-month-old lean (CT) female mice and in 18-month-old diet-induced obese (DIO) mice fed with a high-fat diet (HFD), or a DHA-enriched HFD. Aging downregulated Prdm16 and UCP1 levels, especially in DIO mice, while DHA partially restored them. Arachidonic acid (AA)-derived LXs and DHA-derived MaRs and PDs were the most abundant SPMs in BAT of young CT mice. Interestingly, the sum of LXs and of PDs were significantly lower in aged DIO mice compared to young CT mice. Some of the SPMs most significantly reduced in obese-aged mice included LXB

Indexed as

Dietary SupplementsAdipose Tissue, BrownAgingAnimalsDiet, High-FatDocosahexaenoic AcidsFemaleLipid MetabolismLipidomicsLipidsMiceMice, Inbred C57BLObesityDocosahexaenoic AcidsLipidsagingbrown adipose tissueDHAlipidomicobesityproresolving lipid mediators

Identifiers

PMID33960028
PMCPMC12315960
OpenAlexW3158593171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.